Statins: The growths on your fingers that could signal potentially fatal rhabdomyolysis

Rhabdomyolysis and statins

The Mayo Clinic reassures that “the risk of very serious side effects is extremely low, and calculated in a few cases per million people taking statins”.

In a report on statin-induced rhabdomyolysis published in the journal Physiotherapy Canada, researchers sought to identify which statins may carry a higher risk of rhabdomyolysis.

They found that Simvastatin was the most common medication reported in association with rhabdomyolysis, most commonly taken at a dose of 40 mg/day.

The report continued: “Fewer cases reported the use of cerivastatin, lovastatin, rosuvastatin, pravastatin and fluvastatin.”